Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyWed, 17 Jul 2024 18:10:57 +0200Wed, 17 Jul 2024 14:11:00 +0200Human medicines European public assessment report (EPAR): HBVaxPro, hepatitis B vaccine (recombinant DNA), Date of authorisation: 27/04/2001, Revision: 33, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/hbvaxproHuman medicines European public assessment report (EPAR): HBVaxPro, hepatitis B vaccine (recombinant DNA), Date of authorisation: 27/04/2001, Revision: 33, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/hbvaxproWed, 17 Jul 2024 14:11:00 +0200Human medicineHBVaxPro-H-C-373-A20-0015 : EPAR - Scientific Conclusionhttps://www.ema.europa.eu/system/files/documents/scientific-conclusion/wc500046817_en.pdfHBVaxPro-H-C-373-A20-0015 : EPAR - Scientific Conclusionhttps://www.ema.europa.eu/system/files/documents/scientific-conclusion/wc500046817_en.pdfTue, 05 Sep 2006 02:09:21 +0200Human medicine